AI in Personalized Nutrition Market

AI in personalized nutrition applies artificial intelligence to analyze individual biological, behavioral, and lifestyle data, including genetic profiles, microbiome composition, and continuous glucose response, to generate individualized dietary recommendations that move beyond generic nutrition guidance toward precision approaches tailored to each person's unique physiology. As consumer interest in data-driven wellness has grown alongside advancing capability in biomarker testing and AI-driven data interpretation, personalized nutrition platforms have evolved from simple dietary tracking tools toward sophisticated systems incorporating multiple biological data streams.

Demand growth through the 2026-2033 window is closely tied to growing consumer interest in precision, individualized approaches to nutrition and wellness beyond generic dietary guidance, expanding accessibility and declining cost of genetic and microbiome testing supporting broader personalized nutrition platform adoption, and continued AI algorithm advancement improving the accuracy and practical utility of personalized dietary recommendations. Growing corporate wellness program interest in personalized nutrition as an employee health benefit continues to expand the market beyond direct-to-consumer adoption alone.

The market is valued at USD 2.60 Billion in 2026, with platform providers directing substantial investment toward improved AI algorithms and expanded biomarker integration that strengthens the personalization and practical utility of dietary recommendations. By 2033, the market is forecast to reach USD 10.83 Billion, reflecting rapid growth across established individual consumer applications alongside accelerating corporate wellness program adoption.

• The global AI in personalized nutrition market is valued at USD 2.60 Billion in 2026 and is projected to reach USD 10.83 Billion by 2033, expanding at a CAGR of 22.6% across the 2026-2033 forecast period.
• Software/AI Platforms lead the component segment with a 55.0% share in 2026, equivalent to USD 1.43 Billion.
• Individual Consumers remain the dominant end-user segment, accounting for 64.0% of global demand, or USD 1.66 Billion, in 2026.
• North America commands the largest regional share at 47.0% of the global market in 2026.
• Corporate wellness program adoption is emerging as the fastest-growing end-user segment through 2033.

• Key Growth Drivers

Growth in the AI in personalized nutrition market is driven primarily by growing consumer interest in precision, individualized wellness approaches, as consumers increasingly seek dietary guidance tailored to their unique biological and metabolic characteristics rather than generic, population-level nutrition recommendations.

A second driver is expanding accessibility and declining cost of genetic and microbiome testing, as these previously specialized and expensive testing capabilities have become increasingly accessible to mainstream consumers, supporting broader adoption of biomarker-informed personalized nutrition platforms.

• Key Restraints

The scientific validation of certain personalized nutrition approaches, particularly those based on genetic testing for dietary recommendations, remains an area of ongoing research, creating some skepticism among nutrition scientists and healthcare providers regarding the evidence base for specific personalization claims.

Additionally, the cost of comprehensive biomarker testing and ongoing platform subscriptions creates an affordability barrier for broader consumer adoption, particularly for the most sophisticated, multi-biomarker personalized nutrition offerings.

• Market Opportunities

The expansion of corporate wellness program adoption presents a substantial opportunity, as employers increasingly seek differentiated, science-based wellness benefits to support employee health, creating a growing institutional purchaser base for personalized nutrition platforms beyond individual consumer adoption.

A second opportunity lies in continued AI algorithm advancement that improves the accuracy and practical utility of personalized dietary recommendations across an expanding range of biomarkers and health goals. Companies that successfully advance this algorithmic sophistication stand to differentiate their offerings and build stronger consumer trust and engagement.

• By Component

Software/AI Platforms lead the component segment, accounting for 55.0% of global market value in 2026, equivalent to USD 1.43 Billion. Their leadership reflects the central role of AI-driven analysis and recommendation software in translating biological data into actionable dietary guidance. Services represent a significant, established component category. Testing Kits (DNA/Microbiome) represent the fastest-growing component category through 2033, driven by expanding consumer interest in biomarker-informed personalization.

• By End User

Individual Consumers form the leading end-user segment, representing 64.0% of global demand in 2026, or USD 1.66 Billion, reflecting strong direct-to-consumer demand for personalized dietary guidance. Healthcare Providers & Clinics represent a significant, established end-user category. Corporate Wellness Programs represent the fastest-growing end-user category, propelled by growing employer interest in differentiated, science-based wellness benefits.

North America

North America holds the largest regional share, at 47.0% of the global market in 2026, equivalent to USD 1.22 Billion. The region's leadership reflects strong consumer wellness technology adoption and substantial investment in personalized nutrition platform development across the United States and Canada.

Europe

Europe accounts for 27.0% of the global market in 2026, valued at USD 0.70 Billion. Demand is supported by growing consumer interest in precision nutrition and expanding biomarker testing accessibility across major European markets.

Asia Pacific

Asia Pacific represents 20.0% of the global market in 2026, or USD 0.52 Billion. Growth is underpinned by rising health consciousness and expanding personalized wellness technology adoption across China, Japan, and South Korea.

Latin America

Latin America contributes 3.0% of the global market in 2026, equivalent to USD 0.08 Billion. Growth remains at an early stage, tied to gradual personalized nutrition platform adoption in Brazil and Mexico.

Middle East & Africa

Middle East & Africa holds 3.0% of the global market in 2026, valued at USD 0.08 Billion. Growth remains limited, tied to early-stage regional adoption of personalized wellness technology.

The global AI in personalized nutrition market is fragmented, with a mix of dedicated personalized nutrition startups, genetic and microbiome testing companies, and broader digital health platforms competing for consumer and institutional adoption. Competition centers on AI algorithm sophistication and recommendation accuracy, breadth of biomarker testing integration, and the ability to build sustained user engagement translating recommendations into behavior change. Companies are increasingly differentiating through expanded scientific validation rather than competing on testing breadth alone.

Key Market Players

• Nutrigenomix Inc.
• ZOE Global Limited
• DayTwo, Inc.
• Viome Life Sciences, Inc.
• Segterra, Inc.
• Season Health, Inc.
• Suggestic, Inc.
• Zipongo, Inc.
• PlateJoy, Inc.
• Noom, Inc.

By Component

• Software/AI Platforms
• Testing Kits (DNA/Microbiome)
• Services

By End User

• Individual Consumers
• Healthcare Providers & Clinics
• Corporate Wellness Programs
• Others

By Personalization Basis

• Genetic Data
• Microbiome & Biomarker Data

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa